Summary
Christopher Nobles is a Lead Bioinformatician with 11 years of experience designing and scaling computational biology solutions for oncology diagnostics, gene and cell therapies, and genomic engineering. He has led development of NGS-based assays and cloud-native pipelines that improved sensitivity, specificity, and scalability for multi-cancer early detection and aneuploidy detection. His work spans algorithm development (contamination estimation, copy-number and methylation analyses), ML model design, and practical assay translation from feasibility to validated clinical workflows. Christopher has driven cross-functional programs at Exact Sciences and Natera and advised clients as an independent consultant on biomarker discovery and study design. He combines deep wet-lab collaboration experience from academic gene therapy projects with a track record of converting novel analytics into production-ready pipelines intended for millions of samples. Notably, he developed widely applied integration-site and QC utilities used across gene therapy and CART product evaluations.
11 years of coding experience
10 years of employment as a software developer
Doctor of Philosophy (Ph.D.) Molecular Virology and Microbiology, Doctor of Philosophy (Ph.D.) Molecular Virology and Microbiology at Baylor College of Medicine
B.S. Biochemical and Chemical Engineering, B.S. Biochemical and Chemical Engineering at Colorado School of Mines
Postdoctoral Researcher Microbiology Virology Gene and Cell Therapy, Postdoctoral Researcher Microbiology Virology Gene and Cell Therapy at University of Pennsylvania